NECTIN4 and urothelial carcinoma: Two available MIBC studies on this topic reported similar Nectin‐4 positivity rates of 80% (57/82) and 68% (15/22) in pure urothelial carcinoma NOS, when compared with our cohort, which showed a rate of 70% (95/136) [15, 19].